The observational cohort of the CAMP (Childhood Asthma Management Program) evaluated 943 of 1041 participants until they reached their adulthood height (22.2 to 27.6 years). Results revealed that children who had taken budesonide decreased their attained adult heights by an average of 1.2 cm (or approx. ½ inch). The height difference was seen 1-2 years after treatment initiation and continued into adulthood but did not get worse.  Have any parents of your pediatric patients expressed concern about their children’s future growth

For more information, please visit NEJM

Advertisements